Dr. Lal PathLabs Limited

NSE:LALPATHLAB.NS

3312.7 (INR) • At close October 17, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

20232022202120202019201820172016201520142013201220112010
Operating Activities:
Net Income 3,5772,4113,502.912,964.792,275.872,004.671,717.852,332.9792,007.1581,396.981,192.06802.01664.22447.31
Depreciation & Amortization 1,4361,5021,081.07771.98728.1382.2330.61281.654282.812281.9272.29203.98198.34136.03
Deferred Income Tax 025-103.27-42.4-153.85-108.69-62.6-702.594-707.84-531.35-486.78-344.37-197.520
Stock Based Compensation 217226323203.74166.37150.46116.9276.283-34.669242.19155.46249.656.430
Change In Working Capital 357355-167.06366.71121.6793.0495.01-81.25868.524-321.18-94.48-28.11-0.361.79
Accounts Receivables -7233.35-179.98-204.39-40.82-178.75-32.27-100.27-69.95-83.654-67.68-62.8100
Inventory -35187-99.83144.02-284.25-12-94.28-33.922-2.376-26.18-29.16-23.5216.26-13.35
Accounts Payables 30592.2734.33269.2380.74146.53133.3104.5000000
Other Working Capital 15942.3878.42157.8866137.26189.29-47.33670.9-295-65.32-4.59-16.6215.14
Other Non Cash Items 3,01739-169.8-283.32-299.26-336.31-227.14-190.702-147.482-90.04-58.97-1.8510.17-167.26
Operating Cash Flow 5,7134,5604,466.943,981.52,838.92,185.371,970.651,716.3611,468.503978.5979.58881.31681.28417.87
Investing Activities:
Investments In Property Plant And Equipment -575-446-4,761.43-595.9-796.17-420.38-724.69-515.907-441.274-352.93-327.63-196.2-211.26-240.74
Acquisitions Net 5-178-4,575.97-31.5-277.59-8.14-23.22-168.371-35.728-7.5-232.01-4.25-163.18-196.17
Purchases Of Investments -9,817-11,347-8,476.81-12,580.15-11,025.04-6,113.29-4,866.39-4,969.345-3,958.483-2,185.6-1,583.61-1,225.61-326.51-542.01
Sales Maturities Of Investments 9,6918,78712,808.9810,687.0511,422.744,818.793,903.133,997.3982,834.8941,541.611,198.47745.9420.1764.43
Other Investing Activites 20311512.76400.34414.92725.65-11.58249.52582.628109.0847.8929.8118.328.6
Investing Cash Flow -696-2,873-4,492.47-2,120.16-261.14-997.37-1,722.75-1,406.701-1,517.963-895.34-896.89-650.35-262.55-185.89
Financing Activities:
Debt Repayment -1,533-1,090-3,454.23-235.27-200.26-0.030000-4.870-124.69-0.11
Common Stock Issued 3591.381.491.661.5129.7835.809160.841105.3800.1300
Common Stock Repurchased 0-720-3,454.23-0.01200.26-0.03-0.3100000-65.96-240
Dividends Paid -2,011.69-1,030.13-1,166.6-994.83-1,555.02-551.9-318.45-377.959-156.276-104.17-96.63-149.91-96.54-149.42
Other Financing Activities -259-19,438.19-156.94-351.09-2.16413.72-2.32-0.97-9.17-0.461.83-96.25168
Financing Cash Flow -4,045-2,8321,364.51-1,385.56-1,904.45-552.61125.05-344.4693.596-7.96-101.96-147.95-383.44-221.53
Other Information:
Effect Of Forex Changes On Cash 00.36-0.0100.02000003.9610.1801.55
Net Change In Cash 5,655.2-1,1451,338.97475.78673.31635.39372.95-34.809-45.86475.2-15.3193.1935.2912
Cash At End Of Period 8,3032,6373,781.952,442.981,967.181,293.87658.48152.176186.986232.84157.64172.9579.7644.47